Affinage

ATP2B3

Plasma membrane calcium-transporting ATPase 3 · UniProt Q16720

Length
1220 aa
Mass
134.2 kDa
Annotated
2026-04-28
20 papers in source corpus 12 papers cited in narrative 12 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

ATP2B3 (PMCA3) is a plasma membrane Ca²⁺-ATPase that extrudes cytoplasmic Ca²⁺ to maintain intracellular calcium homeostasis, with critical roles in neuronal signaling and adrenal aldosterone regulation. In the brain, PMCA3 localizes to cerebellar granule cell processes and hippocampal dendritic fields, where it controls sub-plasma membrane Ca²⁺ microdomains; mutations in its catalytic P-domain (G733R) or calmodulin-binding region (E1081Q) impair Ca²⁺ extrusion in a splice variant–dependent manner and cause cerebellar ataxia (PMID:28807751, PMID:36207321, PMID:7770003). In adrenal aldosterone-producing adenomas, somatic loss-of-function mutations near transmembrane codons 416–426 abolish Ca²⁺ export, generate Na⁺-dependent inward currents that depolarize the plasma membrane, elevate intracellular Ca²⁺, and drive CYP11B2 (aldosterone synthase) expression and autonomous aldosterone production (PMID:23416519, PMID:27035656, PMID:24082052). PMCA3 activity is negatively regulated by phosphorylation-independent binding of 14-3-3ε, which reduces Ca²⁺ clearance following intracellular Ca²⁺ transients (PMID:18029012).

Mechanistic history

Synthesis pass · year-by-year structured walk · 8 steps
  1. 1994 Medium

    Mapping ATP2B3 to Xq28 established it as an X-linked candidate for neurological disease, framing subsequent genetic studies.

    Evidence FISH, somatic cell hybrid, and linkage analysis in human samples

    PMID:8187550

    Open questions at the time
    • No disease-causing mutations identified at this stage
    • Functional relevance of chromosomal position not tested
  2. 1995 Medium

    Demonstrating that PMCA3 protein localizes to cerebellar granule cell processes and hippocampal dendritic fields revealed its neuron-specific Ca²⁺ extrusion role, distinguishing it from ubiquitous PMCA isoforms.

    Evidence Immunohistochemistry and in situ hybridization in rat brain

    PMID:7770003

    Open questions at the time
    • Localization shown only in rat; human tissue confirmation lacking
    • No functional consequence of regional expression tested
  3. 2007 High

    Identification of 14-3-3ε as a phosphorylation-independent inhibitor of PMCA3 pump activity established the first known regulatory partner that attenuates Ca²⁺ clearance.

    Evidence Two-hybrid, co-immunoprecipitation, GST pull-down, aequorin-based Ca²⁺ measurements in CHO cells

    PMID:18029012

    Open questions at the time
    • Physiological context of 14-3-3ε regulation (e.g., neuronal vs. adrenal) not addressed
    • Binding site on PMCA3 not mapped
  4. 2012 Medium

    Showing that PMCA3 knockdown in PC12 cells accelerates neurite outgrowth and triggers compensatory upregulation of PMCA1/4 and SERCA demonstrated that PMCA3 loss remodels Ca²⁺ signaling networks during neuronal differentiation.

    Evidence Antisense stable transfection in PC12 cells with differentiation assays and immunoblot

    PMID:22921123

    Open questions at the time
    • Relevance to in vivo neuronal development not tested
    • Compensatory mechanisms complicate isolation of PMCA3-specific roles
  5. 2013 High

    Discovery of recurrent somatic ATP2B3 mutations in aldosterone-producing adenomas, coupled with electrophysiological evidence for membrane depolarization and CYP11B2/NR4A2 upregulation, established a direct mechanistic link between PMCA3 loss-of-function and autonomous aldosterone secretion.

    Evidence Exome sequencing of APA cohort; patch-clamp on primary adenoma cells; overexpression in HAC15 cells with gene expression readout

    PMID:23416519 PMID:24082052

    Open questions at the time
    • Precise structural basis for mutation-induced ion leak not resolved
    • Whether mutations act purely through loss of Ca²⁺ extrusion or also gain-of-function Na⁺ conductance remained unclear
  6. 2016 High

    Mechanistic dissection of the L425_V426del mutation resolved that APA-linked ATP2B3 mutations simultaneously abolish Ca²⁺ pump function and introduce a Na⁺-dependent inward current, explaining both elevated intracellular Ca²⁺ and membrane depolarization.

    Evidence Ca²⁺ imaging in NCI-H295R and HEK-293 cells, patch-clamp electrophysiology, aldosterone production assays

    PMID:27035656

    Open questions at the time
    • Na⁺ conductance pathway through the mutant pump not structurally characterized
    • In vivo confirmation of dual mechanism lacking
  7. 2017 Medium

    Identification of the catalytic P-domain G733R mutation as impairing Ca²⁺ handling, supported by molecular dynamics, linked PMCA3 catalytic domain integrity to cerebellar ataxia pathogenesis.

    Evidence Cellular Ca²⁺ assays combined with homology modeling and molecular dynamics

    PMID:28807751

    Open questions at the time
    • No patient genotype–phenotype segregation data provided
    • Structural model based on homology, not experimental structure
  8. 2022 Medium

    Demonstrating that the ataxia-linked E1081Q mutation near the calmodulin-binding domain has opposite effects in the 'a' versus 'b' splice variants revealed that PMCA3 splice context determines whether a mutation causes gain or loss of sub-PM Ca²⁺ extrusion.

    Evidence Sub-plasma membrane Ca²⁺ microdomain measurements and pump activity assays comparing splice variants

    PMID:36207321

    Open questions at the time
    • Relative expression of splice variants in cerebellar neurons not quantified
    • How splice-specific effects translate to selective cerebellar vulnerability unknown

Open questions

Synthesis pass · forward-looking unresolved questions
  • Key unresolved questions include the high-resolution structural basis for mutation-induced Na⁺ leak through PMCA3, the in vivo contribution of 14-3-3ε regulation to neuronal or adrenal Ca²⁺ homeostasis, and whether PMCA3 splice variant ratios explain cell-type-specific disease manifestations.
  • No cryo-EM or crystal structure of PMCA3 available
  • In vivo knockout/knockin mouse models with neuronal or adrenal phenotyping not reported in the timeline
  • Relative pathogenic contribution of Ca²⁺ extrusion loss versus Na⁺ leak in APA not resolved

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0140657 ATP-dependent activity 5 GO:0005215 transporter activity 4
Localization
GO:0005886 plasma membrane 5
Pathway
R-HSA-382551 Transport of small molecules 5 R-HSA-112316 Neuronal System 2 R-HSA-162582 Signal Transduction 2

Evidence

Reading pass · 12 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2013 Somatic hotspot mutations in ATP2B3 (encoding plasma membrane Ca2+ ATPase) were identified in aldosterone-producing adenomas (APAs). Electrophysiological ex vivo studies on primary adrenal adenoma cells provided evidence for inappropriate membrane depolarization in cells with ATP2B3 alterations, leading to autonomous aldosterone secretion. Exome sequencing, functional in vitro studies, electrophysiological ex vivo patch-clamp Nature genetics High 23416519
2013 Somatic ATP2B3 mutations in APAs result in upregulation of CYP11B2 (aldosterone synthase) gene expression and its transcriptional regulator NR4A2 in HAC15 adrenal cells, establishing a mechanistic link between ATP2B3 loss-of-function and dysregulated aldosterone production. Overexpression in HAC15 adrenal cells, gene expression assays, whole-cell patch-clamp Hypertension High 24082052
2016 The APA-associated ATP2B3 Leu425_Val426del mutation causes: (1) loss of physiological Ca2+ pump function (reduced Ca2+ export capacity); (2) increased Ca2+ influx via depolarization-activated Ca2+ channels; and (3) a Na+-dependent inward current that strongly depolarizes the plasma membrane—collectively promoting CYP11B2 expression and aldosterone production. Ca2+ measurements in NCI-H295R and HEK-293 cells, patch-clamp electrophysiology, mRNA expression assays, aldosterone production assays Endocrinology High 27035656
2007 14-3-3epsilon protein interacts with PMCA3 (ATP2B3) in a phosphorylation-independent manner, and this interaction inhibits PMCA3 pump activity, reducing the ability of cells to restore basal Ca2+ concentration following an InsP3-induced Ca2+ transient. Two-hybrid assay, co-immunoprecipitation in HeLa cells, GST pull-down, aequorin-based Ca2+ measurement in CHO cells Cell calcium High 18029012
1995 PMCA3 protein is expressed in rat brain neurons and localizes primarily to granule cell processes in the cerebellum (granule cell and molecular layers), choroid plexus, and hippocampal dendritic fields, with localization pattern co-distributing with the axonal marker GAP-43 in cerebellar molecular layer. In situ hybridization, immunoblot with affinity-purified anti-peptide antibodies, immunohistochemistry Brain research. Molecular brain research Medium 7770003
1994 ATP2B3 (PMCA3) was localized to human chromosome Xq28 by fluorescence in situ hybridization (FISH), somatic cell hybrid analysis, and genetic linkage analysis, identifying it as a candidate gene for X-linked neurological diseases mapping to distal Xq. FISH, somatic cell hybrid analysis, genetic linkage analysis Cytogenetics and cell genetics Medium 8187550
2017 A novel PMCA3 G733R mutation in the catalytic P-domain impairs the pump's ability to control cellular Ca2+ handling under both basal and stimulated conditions, with homology modeling and molecular dynamics indicating the mutation disrupts the 3D configuration of the local P-domain structure. Biochemical Ca2+ handling assays in cells, homology modeling, molecular dynamics simulation Biochimica et biophysica acta. Molecular basis of disease Medium 28807751
2022 The ataxia-linked E1081Q mutation in ATP2B3 immediately upstream of the calmodulin-binding domain has a splicing variant-dependent effect: in the full-length 'b' variant it abolishes sub-plasma membrane Ca2+ reduction capacity, while in the truncated 'a' variant it increases Ca2+ extrusion activity in sub-PM microdomains. Biochemical Ca2+ pump activity assays, sub-plasma membrane Ca2+ microdomain measurements, molecular studies of splice variants Cell death & disease Medium 36207321
2012 Downregulation of PMCA3 in PC12 cells accelerates differentiation, forms longer neurites, alters expression of voltage-dependent Ca2+ channels (VDCCs) increasing their contribution to Ca2+ influx, and triggers compensatory upregulation of constitutive PMCA1/PMCA4 isoforms and SERCA. Antisense stable transfection in PC12 cells, dibutyryl-cAMP differentiation assay, Ca2+ influx measurements, immunoblot for PMCA isoforms and SERCA Cell calcium Medium 22921123
2021 A novel somatic ATP2B3 K416_F418delinsN mutation in APA causes increased CYP11B2 expression and aldosterone production when transfected into HAC15 adrenal cells, confirming functional pathogenicity of mutations in the codon 416–418 region. Somatic mutation sequencing, HAC15 cell transfection, CYP11B2 expression and aldosterone production assay Cancers Low 34572956
2023 ATP2B3 inhibition (knockdown) in HT-22 neuronal cells alleviates erastin-induced ferroptosis by modulating the P62-KEAP1-NRF2-HO-1 oxidative stress pathway, reducing ROS production and reversing ferroptosis-associated cell death. siRNA knockdown in HT-22 cells, ROS measurement, protein expression analysis (P62, NRF2, HO-1, NQO1, KEAP1), cell viability assay, TMT-based proteomics International journal of molecular sciences Low 37298147
2011 PMCA3 knockdown in GH3 pituitary cells results in increased GAD65 expression, indicating that PMCA3 participates in the regulation of GABA synthesis through Ca2+ homeostasis maintenance. Antisense knockdown in GH3 cells, enzyme activity assays (GAD, GABA-T), immunoblot Biochemical and biophysical research communications Low 21798237

Source papers

Stage 0 corpus · 20 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2013 Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nature genetics 443 23416519
2013 Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas. Hypertension (Dallas, Tex. : 1979) 135 24082052
2006 CLA-1 and its splicing variant CLA-2 mediate bacterial adhesion and cytosolic bacterial invasion in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 57 17071747
2016 Cellular Pathophysiology of an Adrenal Adenoma-Associated Mutant of the Plasma Membrane Ca(2+)-ATPase ATP2B3. Endocrinology 50 27035656
1995 Localization of the plasma membrane Ca(2+)-ATPase isoform PMCA3 in rat cerebellum, choroid plexus and hippocampus. Brain research. Molecular brain research 45 7770003
1994 Localization of two genes encoding plasma membrane Ca2+ ATPases isoforms 2 (ATP2B2) and 3 (ATP2B3) to human chromosomes 3p26-->p25 and Xq28, respectively. Cytogenetics and cell genetics 32 8187550
2011 Dynamic alternations in cellular and molecular components during blossom-end rot development in tomatoes expressing sCAX1, a constitutively active Ca2+/H+ antiporter from Arabidopsis. Plant physiology 27 21464475
2007 Inhibitory interaction of the 14-3-3 proteins with ubiquitous (PMCA1) and tissue-specific (PMCA3) isoforms of the plasma membrane Ca2+ pump. Cell calcium 26 18029012
2012 Downregulation of PMCA2 or PMCA3 reorganizes Ca(2+) handling systems in differentiating PC12 cells. Cell calcium 24 22921123
2004 Characterization and expression of plasma membrane Ca2+ ATPase (PMCA3) in the crayfish Procambarus clarkii antennal gland during molting. The Journal of experimental biology 24 15277554
2013 Exome sequencing identification of a GJB1 missense mutation in a kindred with X-linked spinocerebellar ataxia (SCA-X1). Human molecular genetics 18 23773993
1989 Analysis of a novel VHS107 haplotype in CLA-2 and WSA mice. Evidence for gene conversion among IgVH genes in outbred populations. The Journal of experimental medicine 14 2584925
2017 A novel PMCA3 mutation in an ataxic patient with hypomorphic phosphomannomutase 2 (PMM2) heterozygote mutations: Biochemical characterization of the pump defect. Biochimica et biophysica acta. Molecular basis of disease 12 28807751
2023 ATP2B3 Inhibition Alleviates Erastin-Induced Ferroptosis in HT-22 Cells through the P62-KEAP1-NRF2-HO-1 Pathway. International journal of molecular sciences 6 37298147
2015 A Novel Somatic Deletion Mutation of ATP2B3 in Aldosterone-Producing Adenoma. Endocrine pathology 5 26481629
2012 Ectopic expression of a maize calreticulin mitigates calcium deficiency-like disorders in sCAX1-expressing tobacco and tomato. Plant molecular biology 5 23007728
2011 GABA-shunt enzymes activity in GH3 cells with reduced level of PMCA2 or PMCA3 isoform. Biochemical and biophysical research communications 4 21798237
2022 The ataxia-linked E1081Q mutation affects the sub-plasma membrane Ca2+-microdomains by tuning PMCA3 activity. Cell death & disease 3 36207321
2021 Characteristics of a Novel ATP2B3 K416_F418delinsN Mutation in a Classical Aldosterone-Producing Adenoma. Cancers 1 34572956
2022 Expression, purification and structure determination of the chlorinase ClA2. Biochemical and biophysical research communications 0 36081280